Latest research on Prednisolone

A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. [PubChem]

Latest findings

We medicated the patients with oral Prednisolone one week before the treatment and for two months thereafter to avoid a potentially severe immune response induced by gene therapy. [source, 2016]
Patients were given a 9-week course of oral Prednisolone as described previously1516. [source, 2016]
Prednisolone is not efficient against LHON32. [source, 2016]
Oral Acetylcysteine 1.2 g BiD, followed by oral Prednisolone 30 mg OD was started when the serum creatinine increased to 428 μmol/L. [source, 2016]
In a prospective but uncontrolled clinical trial, treatment with Prednisolone (0.3–0.5 mg/kg body weight) increased CD4 counts by 119 cells/μl within one year without concomitant changes in HIV viral load [22, 23]. [source, 2016]
Here we report on an investigator-initiated, interventional, two-year, randomized, placebo-controlled prospective clinical trial in Tanzania in which we aimed to reduce HIV immune activation with Prednisolone in order to monitor the effects of this intervention on HIV disease progression. [source, 2016]
While early steroid administration was reported to accelerate recovery of AKI after gross haematuria in IgA nephropathy [13], the use of Prednisolone in WRN is not strongly supported in experimental models and is limited to a single prior case report [14]. [source, 2016]
An investigator-initiated, two-year, randomized, double-blind, placebo-controlled, single-center trial studying the effects of Prednisolone per os in a daily dose of 5 mg on HIV disease progression during the early phase HIV infection (CDC stage A1, A2, B2, B2). [source, 2016]
A total of 326 patients were randomized; 163 study participants received placebo and 163 study participants received Prednisolone. [source, 2016]
Study participants received Prednisolone per os in a daily dose of 5 mg or placebo self-administered by the study participants at home. [source, 2016]